BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Hwa Young Song, Hyo Keun Lee, June Sung Lee, Jong Yeon Kim, Yun Hyuk Yim, Tae Jun Song, Won Ki Bae, Nam-Hoon Kim, Kyung-Ah Kim. Risk Factors of Cryptogenic Hepatocellular Carcinoma in Patients with Low Body Mass Index or without Metabolic SyndromeThe Korean Journal of Internal Medicine 2012; 27(1): 47 doi: 10.3904/kjim.2012.27.1.47
2
Ekram W. Abd El-Wahab, Ashraf Mikheal, Fathallah Sidkey, Hanan Z. Shatat. Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian PatientsJournal of Medical Virology 2015; 87(3): 428 doi: 10.1002/jmv.24092
3
Tina M. St. John. Integrative Medicine2007; : 237 doi: 10.1016/B978-1-4160-2954-0.50027-2
4
Ramón Bataller. Time to ban smoking in patients with chronic liver diseasesHepatology 2006; 44(6): 1394 doi: 10.1002/hep.21484
5
Niamh E Mangan, Ka Yee Fung. Type I interferons in regulation of mucosal immunityImmunology & Cell Biology 2012; 90(5): 510 doi: 10.1038/icb.2012.13
6
Tuyyab Hassan, Corey Sievers, Kiran Anna. Hepatitis C Treatment Response in Patients with a Tobacco History: An Inner City Hospital ExperienceAmerican Journal of Gastroenterology 2010; 105: S95 doi: 10.14309/00000434-201010001-00254
7
Swati Joshi-Barve, Kiranmayi Amancherla, Madhuvanti Patil, Aruni Bhatnagar, Stephanie Mathews, Leila Gobejishvili, Matthew Cave, Craig McClain, Shirish Barve. Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-α: relevance to hepatitis CFree Radical Biology and Medicine 2009; 47(1): 47 doi: 10.1016/j.freeradbiomed.2009.03.021
8
Amy K. Silberbogen, Erin W. Ulloa, E. Amy Janke, DeAnna L. Mori. Psychosocial Issues and Mental Health Treatment Recommendations for Patients With Hepatitis CPsychosomatics 2009; 50(2): 114 doi: 10.1176/appi.psy.50.2.114
9
Carol Reid, Mary Fenech, Lee Jones, Nasim Salehi. Nurse practitioner interventions for smokers with chronic hepatitis CJournal of the American Association of Nurse Practitioners 2020; 32(5): 380 doi: 10.1097/JXX.0000000000000311
10
H. PATEL, E. J. HEATHCOTE. When to treat and the benefits of treating hepatitis C in patients with haemophiliaHaemophilia 2009; 15(1): 20 doi: 10.1111/j.1365-2516.2008.01917.x
11
Tina M. St. John. Integrative Medicine2012; : 171 doi: 10.1016/B978-1-4377-1793-8.00019-4
12
José L. Alonso-Martínez, Francisco J. Anniccherico-Sánchez, Miren Urbieta-Echezarreta, Jose L. Garcia-Sanchotena, Fernando Olaz-Preciado. Hemodynamic effects of chronic smoking in liver cirrhosis: a role for adrenomedullinEuropean Journal of Gastroenterology & Hepatology 2010; 22(5): 513 doi: 10.1097/MEG.0b013e328335b2b2
13
Nathan Ford, Catherine Kirby, Kasha Singh, Edward J Mills, Graham Cooke, Adeeba Kamarulzaman, Philipp duCros. Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysisBulletin of the World Health Organization 2012; 90(7): 540 doi: 10.2471/BLT.11.097147
14
Wei-Chun HuangFu, Jianghuai Liu, Ronald N. Harty, Serge Y. Fuchs. Cigarette smoking products suppress anti-viral effects of Type I interferon via phosphorylation-dependent downregulation of its receptorFEBS Letters 2008; 582(21-22): 3206 doi: 10.1016/j.febslet.2008.08.013
15
Abdel-Rahman El-Zayadi. Heavy smoking and liverWorld Journal of Gastroenterology 2006; 12(38): 6098-6101 doi: 10.3748/wjg.v12.i38.6098